Prenatal therapies: a Points to Consider framework for responsible innovation
Bibliographic record
Abstract
Prenatal therapies represent an emerging frontier in healthcare, enabling medical intervention at the fetal stage to address severe congenital conditions before irreversible harm occurs. As these transformative interventions transition from bench to bedside, significant ethical, legal, and governance challenges arise, particularly concerning maternal-fetal risk-benefit dynamics, informed consent, and regulatory oversight. Recognizing the need for structured and adaptive ethical guidance, we propose a “Points to Consider” (P2C) Framework, developed through a multidisciplinary initiative involving experts in drug development, bioethics norms, human rights, and governance, based on a review of international scientific, regulatory, and ethical literature. The P2C integrates those considerations into nine thematic points addressing: maternal and fetal well-being; risk-benefit assessment, responsible research and clinical care, emerging technology, public engagement, funding sustainability, public health integration, lifecycle governance, and international collaboration. The P2C is designed to support the entire research-to-clinic continuum, fostering multidisciplinary global dialogue. By anchoring prenatal therapeutic innovations within international human rights norms, bioethics standards, and anticipatory governance practices, the P2C aims to ensure that future interventions are safe, ethically robust, and socially aligned. This initiative lays the groundwork for responsibly navigating the complex ethical landscape of prenatal medicine, with implications for policy, clinical practice, and global health equity.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.066 | 0.028 |
| Meta-epidemiology (narrow) | 0.002 | 0.001 |
| Meta-epidemiology (broad) | 0.001 | 0.003 |
| Bibliometrics | 0.005 | 0.003 |
| Science and technology studies | 0.012 | 0.095 |
| Scholarly communication | 0.024 | 0.022 |
| Open science | 0.007 | 0.017 |
| Research integrity | 0.025 | 0.017 |
| Insufficient payload (model declined to judge) | 0.007 | 0.002 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".